| Title |
Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2008
|
| DOI | 10.1002/14651858.cd005536.pub2 |
| Pubmed ID | |
| Authors |
Carlos E Rodriguez-Martinez, Monica Sossa, Juan Manuel Lozano |
| Abstract |
Strong evidence supports the use of metered-dose inhalers combined with a spacer for delivering rapid-acting inhaled beta-2 agonists in the treatment of acute exacerbations of asthma in children. The high cost and lack of availability of commercially produced spacers however, have limited their use in developing countries. |
Twitter Demographics
The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 80% |
| Cameroon | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 60% |
| Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Portugal | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 144 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 16 | 11% |
| Student > Bachelor | 13 | 9% |
| Student > Ph. D. Student | 10 | 7% |
| Researcher | 9 | 6% |
| Student > Doctoral Student | 9 | 6% |
| Other | 36 | 24% |
| Unknown | 54 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 38% |
| Nursing and Health Professions | 15 | 10% |
| Social Sciences | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 1% |
| Psychology | 2 | 1% |
| Other | 9 | 6% |
| Unknown | 59 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#1,222,127
of 24,547,718 outputs
Outputs from Cochrane database of systematic reviews
#2,679
of 12,931 outputs
Outputs of similar age
#2,141
of 70,565 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 56 outputs
Altmetric has tracked 24,547,718 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,931 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 70,565 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.